total warfare

comparison of efficacy between nateglinide and repaglinide in treating type 2 diabetes: a randomized controlled double-blind clinical trial

那格列奈与瑞格列奈治疗2型糖尿病的随机双盲对照研究

metabolic characteristics of nateglinide in isolated hepatocytes of rat

那格列奈在大鼠游离肝细胞中的代谢特点

elucidation of oral hypoglycemic drug nateglinide by nmr

降糖药物那格列奈的核磁共振谱解析

molecular recognition in in-situ nateglinide imprinted chiral stationary phase

原位聚合那格列奈分子印迹手性固定相的分子识别特性研究

the random, double-blind and controlled study on the efficacy and safety of nateglinide in the treatment of type 2 diabetes

那格列奈治疗2型糖尿病的有效性和安全性的随机、双盲、对照研究

determination of nateglinide in human plasma by rp-hplc with column switching technique

柱切换RP-HPLC测定血浆中那格列奈的浓度

determination of nateglinide and its related substances by hplc

HPLC法测定那格列奈含量及有关物质

Conclusion Nateglinide was well tolerated, safe and effective in reducing postprandial hyperglycemia in subjects with IGT.

结论那格列奈可有效降低IGT个体的餐后血糖，安全性和耐受性好。

to optimize the formula of the double-layer tablet of nateglinide rapid-release layer and metformin hydrochloride sustained-release layer.

优选由那格列奈速释层与盐酸二甲双胍缓释层组成的双层片处方。

Finally, owing to its rapid action profile , nateglinide has a relatively low risk of causing hypoglycemia.

最后,由于起效快, 那格列奈造成低血糖风险相对较低.

progress in research of nateglinide and its analogues

那格列奈及其类似物的研究进展

determination of degree of stripping of nateglinide by reversed phase high performance liquid chromatography

反相高效液相色谱法测定那格列奈片剂的溶出度

study of the stability of nateglinide tablets

那格列奈片的稳定性研究

the efficacy and safety of nateglinide in the treatment of impaired glucose tolerance

那格列奈治疗糖耐量低减的有效性和安全性观察

separation of enantiomers of nateglinide by rp-hplc with chiral mobile phase additives

RP-HPLC手性流动相添加法分离测定那格列奈对映异构体

therapeutic effect and safety of nateglinide combined with insulin glargine in treatment of elder patients with type 2 diabetes

那格列奈联合甘精胰岛素治疗老年2型糖尿病的疗效及安全性

preparation and quality investigation of nateglinide dispersible tablets

那格列奈分散片的制备及质量研究

synthesis of nateglinide analogues and their bioactivity determination

那格列奈类似物的合成与活性测定

clinical experience for testifying the efficacy and safety of nateglinide in treating type 2 diabetes

那格列奈治疗2型糖尿病的疗效及安全性的临床试验

conclusion nateglinide is an effective and safe drug in treating type 2 diabetes.

结论那格列奈是安全有效的降血糖药物。

OBJECTIVE To establish the dissolution method for nateglinide tablets.

目的:建立那格列奈片的体外溶出度的测定方法.

method for dissolution determination of nateglinide tablets in vitro

那格列奈片溶出度测定方法

study of determination method on dissolution of nateglinide tablets

纳格列奈片溶出度测定方法的研究

abstract: objective to evaluate the efficacy and safety of nateglinide, a new antidiabetic agent, in the treatment of type 2 diabetes.

摘要：目的评价那格列奈治疗2型糖尿病的有效性和安全性。

to study and evaluate the quality of nateglinide tablets the formulation is screened.

对研制的那格列奈片进行质量评价与研究。

preparation study on nateglinide tablets

那格列奈片的制剂学研究

synthesis of antidiabetic drug nateglinide

那格列奈的合成工艺研究

determination of residual organic solvents in nateglinide by capillary gc

那格列奈中有机溶剂残留量的毛细管气相色谱测定

dissolution study of tablets of nateglinide

那格列奈片的溶出度考察

clinical evaluation on efficacy of domestic nateglinide tablet in patients with type 2 diabetes mellitus

国产那格列奈片对2型糖尿病疗效的临床评价